Pharma Reviews: Dr. Reddy's US drug products pipeline lucrative but hurdles are aplenty

Mumbai: Dr. Reddy's Laboratories Ltd has one of the strongest product pipelines for the US market among Indian generic drug makers but high risks ...
Read more: Dr. Reddy's US drug products pipeline lucrative but hurdles are aplenty

Pharma Reviews: Govt stops $1.3bn Chinese bid for Gland Pharma

Sources say Gland Pharma has a lead in injectibles, an area where Chinese firms lag Indian pharma companies. Gland Pharma says it has pioneered ...
Read more: Govt stops $1.3bn Chinese bid for Gland Pharma

US FDA News: Man of Steel 1 and Man of Steel 2: Recall - Undeclared Drug Ingredient

Use of product found to contained undeclared Sildenafil could result in death. The groups affected include men with diabetes, high blood pressure, high cholesterol, or heart disease.
Read more: Man of Steel 1 and Man of Steel 2: Recall - Undeclared Drug Ingredient

Pharma Reviews: India raises concerns around Chinese firm Fosun's takeover of Gland: Source

India raises concerns around Chinese firm Fosun's takeover of Gland: ... Private-equity backed Gland Pharma and the CCEA, chaired by Indian Prime ...
Read more: India raises concerns around Chinese firm Fosun's takeover of Gland: Source

Pharma Reviews: US business, GST drag Torrent Pharma Q1 net down by 35% at Rs 188 cr

"The Indian pharmaceuticals industry was impacted due to reduction in channel inventory during the transition to Goods and Services Act (GST) and ...
Read more: US business, GST drag Torrent Pharma Q1 net down by 35% at Rs 188 cr

Pharma Reviews: India set to block $1.3 billion Gland Pharma-Fosun deal: Report

Both companies have not been formally notified of the move yet, the report said. ... Fosun, Gland Pharma and the CCEA did not immediately respond to ... Gland Pharma, based in the southern Indian city of Hyderabad, owns four ...
Read more: India set to block $1.3 billion Gland Pharma-Fosun deal: Report

Pharma Reviews: Torrent Pharma Revenue Down 11% To Rs 1374

The Indian pharmaceuticals industry got impacted due to the reduction in channel inventory during the transition to Goods and Services Act and ...
Read more: Torrent Pharma Revenue Down 11% To Rs 1374

Pharma Reviews: Dr. Rao VSV Vadlamudi elected president of Commonwealth Pharmacists Association

Dr. Rao VSV Vadlamudi, president, Indian Pharmaceutical Association (IPA), has been elected as president of Commonwealth Pharmacists ...
Read more: Dr. Rao VSV Vadlamudi elected president of Commonwealth Pharmacists Association

US FDA News: 0.9 Percent Sodium Chloride Injection by ICU Medical: Recall - Presence of Particulate Matter

Injection of particulate matter could potentially lead to limited adverse events such as allergic reactions, local irritation and inflammation in organs or tissues, or other serious adverse health consequences.
Read more: 0.9 Percent Sodium Chloride Injection by ICU Medical: Recall - Presence of Particulate Matter

Pharma Reviews: Torrent Pharma Q1 net profit falls 36% to Rs188 crore

Torrent Pharma's net sales during the period under review stood at Rs 1,348 ... "The Indian pharmaceuticals industry got impacted due to reduction in ...
Read more: Torrent Pharma Q1 net profit falls 36% to Rs188 crore

Pharma Reviews: HT Spotlight | For Kashmiri research scholars, Mohali's NIPER opens doors to Indian diversity

A bright Kashmiri boy, Asrar is pursuing his PhD in pharmaceutical. He belongs to Budgam in Jammu and Kashmir. He adds that this premier institute ...
Read more: HT Spotlight | For Kashmiri research scholars, Mohali's NIPER opens doors to Indian diversity

Pharma Reviews: India is said to block Fosun's $1.3 billion Gland Pharma acquisition

India is poised to reject Shanghai Fosun Pharmaceutical Group Co.'s proposed $1.3 billion takeover of an Indian drugmaker, according to people ...
Read more: India is said to block Fosun's $1.3 billion Gland Pharma acquisition

Pharma Reviews: Indian shares up; SBI jumps on revised saving bank rate

Indian shares up; SBI jumps on revised saving bank rate ... Pharmaceutical stocks are likely to recover gradually until evidence comes through that the ...
Read more: Indian shares up; SBI jumps on revised saving bank rate

Pharma Reviews: Experts see EU Track & Trace Regulations a blessing in disguise for Indian pharma industry

With the European Union Falsified Medicines Directive (EU FMD) coming into force in European Union countries on February 9, 2019, the Indian ...
Read more: Experts see EU Track & Trace Regulations a blessing in disguise for Indian pharma industry

Pharma Reviews: Impact of GST on Healthcare Sector

To make the Indian Tax system more uniform, Goods and Services Tax has been introduced in India from 1st July ... 1) GST and Pharmaceutical industry ... GST will give hassle free business environment to the pharma companies.
Read more: Impact of GST on Healthcare Sector

Pharma Reviews: SC tells MCIA to appoint arbitrator in global dispute

This is the first time in India when a court in the country has invoked section 11 of the Arbitration and Conciliation Act, 2015, asking an independent ...
Read more: SC tells MCIA to appoint arbitrator in global dispute

Pharma Jobs: Hiring PUC, or Bsc MLT, DMLT Field health Care Executive

Company: Yoma Business Solutions Private Limited
Qualification: B.Sc, Class 12
Experience: 0 to 1
Salary: 1.90 to 2.20
location: Bengaluru / Bangalore
Ref: 20893983
Summary: 1 round of interview would be written test of 20 marks 2nd round of interview would be Technical round with operation manager. ....
Read more: Hiring PUC, or Bsc MLT, DMLT Field health Care Executive

Pharma Reviews: Govt keen on investing in R&D in-soft loans for pharma projects: Health Ministry

The main aim of the program is to synergise the strengths of publicly funded R&D institutions and Indian Pharmaceutical Industry. Also financial ...
Read more: Govt keen on investing in R&D in-soft loans for pharma projects: Health Ministry

Pharma Reviews: Indian Startup Funding Of The Week [Funding Galore]

Fork Media: Agnus Capital, the family office of promoters of pharma firm Strides Group invested an undisclosed amount in incubatee firm Fork Media.
Read more: Indian Startup Funding Of The Week [Funding Galore]

Pharma Reviews: Differentiated Products Is The Way Forward For Indian Drug Makers: Pankaj Patel

Murtaza Khorakiwala, Managing Director, Wockhardt, said in fire side discussion titled “Indian pharmaceutical Industry 2030 – The Way Forward' ...
Read more: Differentiated Products Is The Way Forward For Indian Drug Makers: Pankaj Patel

Pharma Reviews: Scheme launched to train Biotech, Pharma students

Scheme launched to train Biotech, Pharma students ... Biotechnology department, Government of India, along with Indian Institute of Chemical ... Convener of Task force committee on Biotechnology and Pharma Industry said that AP ...
Read more: Scheme launched to train Biotech, Pharma students

US FDA News: Compounded Triamicinolone and Moxifloxacin Product for Intravitreal Injection by Guardian Pharmacy Services: Alert to Health Professionals - Serious Adverse Events Reported

Patients had diminished visual function and adverse reactions after injection into the vitreous of the eye at the end of the cataract surgery procedure.
Read more: Compounded Triamicinolone and Moxifloxacin Product for Intravitreal Injection by Guardian Pharmacy Services: Alert to Health Professionals - Serious Adverse Events Reported

Pharma Reviews: Pharma firm Apotex to expand footprint in India

Mumbai, Jul 28 (PTI) Apotex Research, the Indian arm of Canadian pharmaceutical major Apotex Inc, today opened its new global business services ...
Read more: Pharma firm Apotex to expand footprint in India

Pharma Reviews: Pharma sees investors cheering bonds, while stocks decline

On the other hand, Sun Pharmaceutical, the highest-valued Indian entity in the sector, has dropped by 13 per cent to Rs 550 a share on the exchange ...
Read more: Pharma sees investors cheering bonds, while stocks decline

Pharma Reviews: New Zealand Negotiator at Asia Trade Pact Talks Says Countries Should Analyse TRIPS-Plus

... provisions could have big implications for India's generic pharma industry. ... access for the world as well as India's generic pharmaceutical industry.
Read more: New Zealand Negotiator at Asia Trade Pact Talks Says Countries Should Analyse TRIPS-Plus

Pharma Reviews: Pharma firm Apotex to expand footprint in India

Apotex Research, the Indian arm of Canadian pharmaceutical major Apotex Inc, today opened its new global business services office here and said it ...
Read more: Pharma firm Apotex to expand footprint in India

US FDA News: FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death

The U.S. Food and Drug Administration today announced a new comprehensive plan for tobacco and nicotine regulation that will serve as a multi-year roadmap to better protect kids and significantly reduce tobacco-related disease and death. The approach places nicotine, and the issue of addiction, at the center of the agency’s tobacco regulation efforts. The goal is to ensure that the FDA has the proper scientific and regulatory foundation to efficiently and effectively implement the Family Smoking Prevention and Tobacco Control Act. To make certain that the FDA is striking an appropriate balance between regulation and encouraging development of innovative tobacco products that may be less dangerous than cigarettes, the agency is also providing targeted relief on some timelines described in the May 2016 final rule that extended the FDA’s authority to additional tobacco products. The agency will also seek input on critical public health issues such as the role of flavors in tobacco products.
Read more: FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death

US FDA News: Cyclobenzaprine HCl and Amantadine HCl by Apace Packaging: Recall - Potential Mislabeling

Unintentional dosing with Cyclobenzaprine HCl may potentially lead to the development of life-threatening serotonin syndrome, and other serious adverse events.
Read more: Cyclobenzaprine HCl and Amantadine HCl by Apace Packaging: Recall - Potential Mislabeling

Pharma Reviews: Dr Reddy's net profit declines by 56.6% in Q1, scrip tanks over 6%

Dr Reddy's Laboratories (DRL), a Rs.13,800 crore plus Indian pharma company, has received major setback during the first quarter ended June 2017 ...
Read more: Dr Reddy's net profit declines by 56.6% in Q1, scrip tanks over 6%

Pharma Reviews: Dr. Reddy's out licenses infection drug to CHD Bioscience

The Indian pharmaceutical major will also receive milestone payment of $40 million once the product gets approval from the US Food and Drug ...
Read more: Dr. Reddy's out licenses infection drug to CHD Bioscience

Pharma Reviews: Indian pharma gets US FDA booster dose

Indian pharma gets US FDA booster dose ... drug each, the tally of abbreviated new drug application (ANDA) approvals for Indian firms went up to 129 ...
Read more: Indian pharma gets US FDA booster dose

Pharma Reviews: An Indian solution for US healthcare

This is an opportune time for Indian firms and technologies to offer solutions to the U.S. in three healthcare-related areas, namely, pharmaceutical, ...
Read more: An Indian solution for US healthcare

Pharma Reviews: India's FDI regime must garner quality investments

Even though India is one among the top 10 destinations of FDI, the quality of ... Second, if technologically advanced Indian pharmaceutical companies ...
Read more: India's FDI regime must garner quality investments

Pharma Reviews: Mr. Ajay Piramal addresses graduates at Great Lakes Chennai Convocation 2017

Great Lakes has always been ahead in keeping up with changing industry trends ... textile family, we had the courage to move into the Pharma industry. ... opined that Indian graduates will have plenty of job opportunities globally.
Read more: Mr. Ajay Piramal addresses graduates at Great Lakes Chennai Convocation 2017

Pharma Reviews: 11 females to every 100 male workers: Pharma's gender diversity is a sad story

While the female representation in general industry is 15 percent, in pharmaceutical industry it is 11 percent, according to consulting firm Mercer India.
Read more: 11 females to every 100 male workers: Pharma's gender diversity is a sad story

Pharma Reviews: Indian Pharma & Healthcare companies need a 'Digital Prescription'

Indian Pharma and Healthcare companies in need of a 'Digital Prescription'. 2nd edition of the 'India Digital Health Report' analyzes 160 India based ...
Read more: Indian Pharma & Healthcare companies need a 'Digital Prescription'

Pharma Reviews: GlaxoSmithKline Pharma net dips by over 63% in Q1

The pharmaceutical trade channels de-stocked impacting the overall ... pipeline and reviewing these for a possible launch for its Indian patients.
Read more: GlaxoSmithKline Pharma net dips by over 63% in Q1

Pharma Reviews: Finnish workwear multinational opens unit near pharma city

An executive of Lindstrom India explaining about a high-tech washing ... Lindstrom's Indian arm is the leading organised workwear company in India.
Read more: Finnish workwear multinational opens unit near pharma city

Pharma Reviews: Finnish workwear multinational opens unit near pharma city

Finnish workwear multinational opens unit near pharma city ... Lindstrom's Indian arm is the leading organised workwear company in India.
Read more: Finnish workwear multinational opens unit near pharma city

US FDA News: Sterile Drug Products by Cantrell Drug Company: Recall - Lack of Sterility Assurance

Administration of a drug product intended to be sterile that is not sterile could result in serious infections that may be life-threatening.
Read more: Sterile Drug Products by Cantrell Drug Company: Recall - Lack of Sterility Assurance

US FDA News: La Bri's Body Health Atomic and Xplode Capsules by EZ Weight Loss TX: Recall - Undeclared Drug Ingredient

Sibutramine is known to increase blood pressure and/or pulse rate in some patients and may present a risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Read more: La Bri's Body Health Atomic and Xplode Capsules by EZ Weight Loss TX: Recall - Undeclared Drug Ingredient

Pharma Jobs: Scientific Writer's

Company: Indegene Private Limited
Qualification: PhD
Experience: 0 to 4
location: Bengaluru / Bangalore
Ref: 21052384
Summary: Developing & reviewing promotion literature and medico marketing solutions - Emails, blogs, websites and various marketing collatrals.

Read more: Scientific Writer's

Pharma Reviews: Indian pharma team heading to St Petersburg to explore jt ventures

Responding to Russia's call for collaboration in the pharmaceutical sector, India is planning to turn an exhibition for domestic drug producers in St ...
Read more: Indian pharma team heading to St Petersburg to explore jt ventures

Pharma Reviews: Roche, Emcure may end pact to make 2 blockbuster drugs

However, several bio-similar versions of the drug entered the Indian market over the past two years, forcing the company to cut the price. “The JV is not ...
Read more: Roche, Emcure may end pact to make 2 blockbuster drugs

Pharma Reviews: Sensex falls 40 points; Tata Motors, Sun Pharma top losers

Biggest losers in the 30-share index were Tata Motors (1.46%), Sun Pharmaceutical Industries (1.15%), Cipla (1.14%), Coal India (1.11%), Larsen ...
Read more: Sensex falls 40 points; Tata Motors, Sun Pharma top losers

Pharma Reviews: GNH India views that DPCO & quality challenges deny free market access model in pharmacy ...

GNH India, a global source for priority medicines and a full-line pharma wholesaler company, views that quality challenges from regulators, drug price ...
Read more: GNH India views that DPCO & quality challenges deny free market access model in pharmacy ...

Pharma Reviews: Govt snubs ally Shiv Sena, says no evidence note ban, GST harmed common man

Replying to another question, Ms Sitharaman assured the House that the interest of India's pharma and dairy industry will be protected in all ...
Read more: Govt snubs ally Shiv Sena, says no evidence note ban, GST harmed common man

Pharma Reviews: Russia's Chelyabinsk woos Indian pharma

Russia's Chelyabinsk region is seeking proposals from Indian pharmaceutical companies looking to set up manufacturing units there with a local ...
Read more: Russia's Chelyabinsk woos Indian pharma

Pharma Reviews: FPIs up stake in financials, pare pharma holdings

Foreign portfolio investors (FPIs), the biggest non-promoter shareholders in the Indian stock market, increased their allocation to several financial ...
Read more: FPIs up stake in financials, pare pharma holdings

US FDA News: Super Panther 7K by Ultra Shop Supplement: Recall - Undeclared Drug Ingredients

Consumers with diabetes, hypertension, high cholesterol or heart disease often take nitrates; concomitant use of nitrates and PDE-5 can lead to fatal cardiovascular collapse.
Read more: Super Panther 7K by Ultra Shop Supplement: Recall - Undeclared Drug Ingredients

Pharma Reviews: Here's Why Credit Suisse Prefers Indian IT Over Pharma

Stocks of Indian software service providers may be a better bet for investors compared to pharmaceutical shares, according to a report by brokerage ...
Read more: Here's Why Credit Suisse Prefers Indian IT Over Pharma

Pharma Reviews: Anti-Dumping Duty Likely On A Chinese Import Used By Indian Pharma Companies

The government may impose an anti-dumping duty of $72.95 per tonne on imports of a chemical from China, used in pharmaceutical and other ...
Read more: Anti-Dumping Duty Likely On A Chinese Import Used By Indian Pharma Companies

Pharma Reviews: Trading away health

Hyderabad, the historic 'City of Pearls,' well known as the hub of the Indian pharmaceuticals industry, ranks third globally in terms of its production ...
Read more: Trading away health

Pharma Reviews: India is like a pregnant woman, still going through labour pains: Ravi Dharamshi, ValueQuest

India is like a pregnant woman, still going through labour pains: Ravi .... In March 2009, when market made a low, the entire pharma sector was ...
Read more: India is like a pregnant woman, still going through labour pains: Ravi Dharamshi, ValueQuest

Pharma Reviews: 'Egypt's recent economic relations can attract more investors'

Egypt's new investment law and regulations are positive and can attract more Indian investments in the country, especially in the pharmaceutical ...
Read more: 'Egypt's recent economic relations can attract more investors'

US FDA News: Penumbra 3D Revascularization Device by Penumbra: Class I Recall - Wire Material May Break or Separate During Use

Fractured pieces of the delivery wire could be left inside the patient’s brain bloodstream. This or the attempts made to retrieve the fractured pieces can lead to serious adverse health consequences.
Read more: Penumbra 3D Revascularization Device by Penumbra: Class I Recall - Wire Material May Break or Separate During Use

US FDA News: ED-530XT Duodenoscopes by Fujifilm: Safety Communication - Recall Issued, Updated Design and Labeling

Fujifilm issued an Urgent Medical Device Correction and Removal notification, informing customers of its voluntary recall of all ED-530XT duodenoscopes.
Read more: ED-530XT Duodenoscopes by Fujifilm: Safety Communication - Recall Issued, Updated Design and Labeling

Pharma Reviews: 'Egypt's recent economic relations can attract more investors'

"Lots of Indian investments, especially in the field of pharmaceutical industries are interested in working in the Egyptian market... If you look at India, ...
Read more: 'Egypt's recent economic relations can attract more investors'

Pharma Reviews: India: Section 3(D): Hurdle Or Advantage To The Pharmaceutical Sector- An Indian Perspective

Section 3(d) first appeared in the Indian Patents Act 1970 under Section 3 "What are not inventions". Indian companies began manufacturing bulk ...
Read more: India: Section 3(D): Hurdle Or Advantage To The Pharmaceutical Sector- An Indian Perspective

Pharma Reviews: Trump announces $500 million drug packaging project by US firms

In a bid to bring back the American pharmaceuticals glass industry back to the US, President Donald trump announced $500 million investment plan ...
Read more: Trump announces $500 million drug packaging project by US firms

Pharma Reviews: Pharma industry needs vocational specific training in mfr & marketing: Sumit Kumar

Indian pharma industry clearly requires vocational specific training in manufacture and marketing. In the absence of a current and relevant curriculum, ...
Read more: Pharma industry needs vocational specific training in mfr & marketing: Sumit Kumar

US FDA News: FDA clears first neonatal magnetic resonance imaging device

Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU).
Read more: FDA clears first neonatal magnetic resonance imaging device

Pharma Reviews: TRAC, Canada and MedGenome announce a Cancer Immunotherapy solution

This provides a great opportunity for the Indian pharma companies to take advantage from the partnership between MedGenome and TRAC to bring ...
Read more: TRAC, Canada and MedGenome announce a Cancer Immunotherapy solution

Pharma Reviews: Nifty slips 26 points; pharma, metals drag

Sector-wise, PSU Bank fell 1.16 per cent, followed by Pharma (0.92 per cent), Metal (0.92 per cent), IT (0.88 per cent), Commodities (0.79 per cent), ...
Read more: Nifty slips 26 points; pharma, metals drag

Pharma Reviews: CIMS Medica India to host HMS 2017 & CIMS Healthcare Excellence Awards in Mumbai on July 23 ...

CIMS Medica India will host Hospital Management Show (HMS 2017) & CIMS ... The Indian healthcare industry is developing at a remarkable pace and is ... 23 will felicitate the achievers in healthcare and pharmaceutical industry.
Read more: CIMS Medica India to host HMS 2017 & CIMS Healthcare Excellence Awards in Mumbai on July 23 ...

Pharma Reviews: Warning letters and Indian pharma

Greater emphasis on quality will allow India to participate more fully in .... Quality issues are an ongoing challenge for the Indian pharmaceutical ...
Read more: Warning letters and Indian pharma

Pharma Reviews: GST may impact healthcare companies adversely in Q1: ICICI Securities

The Indian pharma market witnessed moderate growth, impacted by destocking before the implementation of GST in July'17, at average 7.7per cent in ...
Read more: GST may impact healthcare companies adversely in Q1: ICICI Securities

Pharma Reviews: Natco Pharma receives EIR from USFDA, stock up 1.05 percent

NEW DELHI: Drug firm Natco Pharma today said it has received establishment inspection report (EIR) from the US health regulator for its Kothur facility ...
Read more: Natco Pharma receives EIR from USFDA, stock up 1.05 percent

Pharma Reviews: Natco Pharma receives successful EIR from USFDA for its Telangana unit

Indian pharmaceutical company Natco Pharma Limited has received successful Establishment Inspection Report (EIR) from the US Food and Drug ...
Read more: Natco Pharma receives successful EIR from USFDA for its Telangana unit

Pharma Reviews: Rajasthan Antibiotics to raise Rs. 25 cr through private equity or venture capital for expansion

The public sector pharma unit has chalked out plans to set up a new ... India's pharmaceutical sector will touch US$ 45 billion The API industry has ...
Read more: Rajasthan Antibiotics to raise Rs. 25 cr through private equity or venture capital for expansion

Pharma Reviews: Time for pharma to make acquisitions in US, says Sanjiv Kaul

Currently, Indian pharma companies are not seized by border tax implications and, therefore, risk could be high for the sector under the Trump ...
Read more: Time for pharma to make acquisitions in US, says Sanjiv Kaul

Pharma Reviews: Gubba Cold Storage plans storage for pharma in Hyderabad

“Hyderabad is the pharma hub of India but there are very few pharma compliant ... We are in the process of creating one facility for pharma industry.
Read more: Gubba Cold Storage plans storage for pharma in Hyderabad

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the Funding Awards to States for FDA Food Safety Modernization Act (FSMA) Produce Safety Implementation

More than 3,000 Americans are estimated to die each year from foodborne illnesses and many more are hospitalized and sickened. Yet most of these illnesses and deaths are preventable. While the U.S. has one of the safest food supplies in the world, Congress entrusted the FDA with new authorities and resources – as part of the FDA Food Safety Modernization Act (FSMA) – to update and strengthen the FDA’s risk-based approach to the oversight of food safety.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the Funding Awards to States for FDA Food Safety Modernization Act (FSMA) Produce Safety Implementation

Pharma Reviews: Sensex closes 244 points up on pharma show, earnings lift

“Pharma sector outperformed followed by a series of US FDA approvals, ... Shares of state-owned HPCL, Indian Oil Corporation, BPCL and ONGC ...
Read more: Sensex closes 244 points up on pharma show, earnings lift

Pharma Reviews: Bullish on one largecap pharma: Rajat Sharma, Sana Securities

Also among midcap pharma companies, despite the crackdown that we ... food and beverages companies in India are moving towards tetra packing ...
Read more: Bullish on one largecap pharma: Rajat Sharma, Sana Securities

Pharma Reviews: Is Indian pharma ready to tap the European market?

Indian drug companies are facing strong headwinds due to prompt regulatory action of United States Food and Drug Administration (USFDA), likely ...
Read more: Is Indian pharma ready to tap the European market?

Pharma Reviews: Cadila shares on steroids; ease pharma pain as giants Sun Pharma, Lupin, Cipla languish

Given the current regulatory issues such as the USFDA, it comes as no surprise that the Pharma Sector in India has posted unhealthy returns.
Read more: Cadila shares on steroids; ease pharma pain as giants Sun Pharma, Lupin, Cipla languish

Pharma Reviews: 'Indian Pharmacovigilance Day Conference 2017' to be held in Hyderabad on July 28

While speaking about Indian pharma industry and new developments in pharmacovigilance sector, Dr Venkatraman said, “Of late, India is also being ...
Read more: 'Indian Pharmacovigilance Day Conference 2017' to be held in Hyderabad on July 28

Product Recall Alerts: Recall alert: This brand of coffee may contain an erectile dysfunction drug

Recall alert: This brand of coffee may contain an erectile dysfunction drug ... Please return the product to Bestherbs Coffee LLC, 4250 Claremont Dr, ...
Read more: Recall alert: This brand of coffee may contain an erectile dysfunction drug

Pharma Reviews: Pharma stocks on mutual funds' radar post price correction

Ashish Ranawade, CIO of Union MF, says: "Indian pharma companies have the inherent capability to manufacture newer products at much cheaper ...
Read more: Pharma stocks on mutual funds' radar post price correction

US FDA News: FDA approves Vosevi for Hepatitis C

The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis.
Read more: FDA approves Vosevi for Hepatitis C

Pharma Reviews: Pharma exports by India to US may rise in 2017-18: CARE

Amid the pricing pressure and fierce competition in the pharma sector, the Indian Pharma exports to the USA may rise in 2017-18, said CARE Ratings ...
Read more: Pharma exports by India to US may rise in 2017-18: CARE

Pharma Reviews: Indian Pharma Companies Need To Spend On R&D

Indian pharma firms need to increase investments in research and development and quality of manufacturing to comply with global regulatory ...
Read more: Indian Pharma Companies Need To Spend On R&D

Pharma Reviews: Pharma exports may go up: Report

The Indian pharmaceutical industry is likely to face competition from other countries to get abbreviated new drug application (ANDA) approval.
Read more: Pharma exports may go up: Report

Pharma Reviews: India: Mergers, Acquisitions And Joint Venture: Trends In Bio-Similar Industries

Mergers and acquisitions (M&As) in Biosimilar industries are primary to ... Aurobindo Pharma Ltd., an Indian generic pharmaceutical industry is ...
Read more: India: Mergers, Acquisitions And Joint Venture: Trends In Bio-Similar Industries

Pharma Reviews: Indian Pharma exports drop during April-May, positive projections ahead : Reports

New Delhi, July 18 (KNN) The pharmaceutical exports from India during the month of April and May dropped by 8.5 per cent, reveals CARE ratings.
Read more: Indian Pharma exports drop during April-May, positive projections ahead : Reports

Pharma Reviews: Hold Sun Pharma, says Sharmila Joshi

Hold Sun Pharma, says Sharmila Joshi ... told CNBC-TV18, "In Sun Pharmaceutical Industries a lot of the negatives are now in the price. ... well as this whole USFDA onslaught that we have seen on the entire Indian pharma space, ...
Read more: Hold Sun Pharma, says Sharmila Joshi

Pharma Reviews: 'Pharma exports drop by 8.5 pc to $2.5 bn'

'Pharma exports drop by 8.5 pc to $2.5 bn' ... Due to pricing pressure and stiff competition, the Pharma exports from India during ... patent and regulatory issues faced by Indian Pharma companies," the report said, released Monday.
Read more: 'Pharma exports drop by 8.5 pc to $2.5 bn'

Pharma Reviews: 1need2know: 10 macro cues for your day on D-Street

The timing of the IOC-Oil India also has to be determined. ... The Indian Pharmaceuticals Industry (IPI) earns around 70% of its revenues from sale of ...
Read more: 1need2know: 10 macro cues for your day on D-Street

Pharma Reviews: More govt support needed to sustain achievement of pharma sector; TN IDMA

Although Union government is supportive to Indian pharmaceutical sector, comprehensive steps are needed to sustain what the pharma sector has ...
Read more: More govt support needed to sustain achievement of pharma sector; TN IDMA

Pharma Reviews: As India becomes younger, spending on healthcare expected to soar

Indian pharma companies are also exporters of products. The US is the main growth market, constituting over 45% of sales for some of the larger ...
Read more: As India becomes younger, spending on healthcare expected to soar

Product Recall Alerts: Recall alert: This brand of coffee may contain an erectile dysfunction drug

Consumers that have New of Kopi Jantan Tradisional Natural Herbs Coffee which is being recalled should stop using/discard/ and contact their doctor.
Read more: Recall alert: This brand of coffee may contain an erectile dysfunction drug

US FDA News: FDA approves new treatment to reduce the risk of breast cancer returning

The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. For patients with this type of cancer, Nerlynx is the first extended adjuvant therapy, a form of therapy that is taken after an initial treatment to further lower the risk of the cancer coming back. Nerlynx is indicated for adult patients who have been previously treated with a regimen that includes the drug trastuzumab.
Read more: FDA approves new treatment to reduce the risk of breast cancer returning

Pharma Reviews: US asks India to ease registration rules for electronic items

Exporters of Indian pharmaceutical products and agricultural items such as mangoes to the US have to carry out tests under the vigilance of American ...
Read more: US asks India to ease registration rules for electronic items

Pharma Reviews: Indian pharma firms need to increase R&D investment: Report

NEW DELHI: Indian pharma firms need to increase investments in research and development and quality of manufacturing to comply with global ...
Read more: Indian pharma firms need to increase R&D investment: Report

Pharma Reviews: Indian Pharma exports to USA may go up in 2017-18: Report

Apart from this, the Indian pharma companies will continue to witness pricing pressure in the US generics market due to consolidation of distribution ...
Read more: Indian Pharma exports to USA may go up in 2017-18: Report

Pharma Reviews: Indian Pharma exports to USA may go up in 2017-18: Report

The Indian Pharmaceuticals Industry (IPI) earns around 70 per cent of its revenues from sale of generic drugs and generates around 50 per cent of its ...
Read more: Indian Pharma exports to USA may go up in 2017-18: Report

Pharma Reviews: Indian Pharma exports to USA may go up in 2017-18: Report

"The Indian pharmaceutical industry is likely to face competition from other countries to get ANDA (Abbreviated New Drug Application) approval.
Read more: Indian Pharma exports to USA may go up in 2017-18: Report

Pharma Reviews: Leadership Is A Juggler's Act

This third cover package, replete with interviews and guest columns, examines what ails the Indian pharma sector. Senior associate editor, C. H. ...
Read more: Leadership Is A Juggler's Act

Pharma Reviews: GST increased Pharma Industry's worries

The Indian pharmaceutical industry ranks third largest in the world by volume of production and 14th in terms of value, thereby accounting for around ...
Read more: GST increased Pharma Industry's worries

Pharma Reviews: Indian investments in Venezuela face no threat: Venezuelan Ambassador to India Augusto Montiel

India, he said, is expanding its presence in Venezuelan oil fields and ... The Venezuelan government has always defended Indian pharmaceutical ...
Read more: Indian investments in Venezuela face no threat: Venezuelan Ambassador to India Augusto Montiel

Pharma Reviews: Strong rupee hits export-heavy IT and pharma sectors

In addition to rupee appreciation, price erosion in the US is the biggest threat faced by Indian pharma exporters. The speed of approval for news drugs ...
Read more: Strong rupee hits export-heavy IT and pharma sectors

Pharma Reviews: Why over dependence on APIs imported from China is harmful for India?

India has proven capabilities in the generic drug formulations, but over dependence on China for sourcing 70-75 per cent of active pharmaceutical ...
Read more: Why over dependence on APIs imported from China is harmful for India?

Pharma Reviews: What would it take to push Indian pharma sector on growth path?

India has been doing exceptionally well in the pharmaceutical sector for the last 20-25 years, but since the country agreed to comply with the WTO's ...
Read more: What would it take to push Indian pharma sector on growth path?

Pharma Reviews: GST: Is It Great Taxation Reorm In India After Independence?

India initiated all efforts towards the implementation of GST for the last seventeen years and .... The Indian pharmaceutical market is estimated at $2.
Read more: GST: Is It Great Taxation Reorm In India After Independence?

Pharma Reviews: Pharma industry in south has great potential in production of drugs for chronic diseases: SV ...

The potential of south Indian pharma industry in production of drugs for chronic diseases is high and it is growing steadily compared to such in other ...
Read more: Pharma industry in south has great potential in production of drugs for chronic diseases: SV ...

Pharma Reviews: Four batches of healthcare professionals trained in reporting ADRs by IPC from Jan 2017

To track adverse drug reactions (ADRs) in Indian population, Union health ministry ... In August 2016, Drug Controller General of India (DCGI) had issued a ... personnel employed in pharmaceutical manufacturing units shall undergo ...
Read more: Four batches of healthcare professionals trained in reporting ADRs by IPC from Jan 2017

Pharma Reviews: Code to ban bribes from companies to doctors in final stages

In response to Indian medical device manufacturers asking to be brought under the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), ...
Read more: Code to ban bribes from companies to doctors in final stages

Pharma Reviews: Pharma sector must cut logistics costs to stay in race: Pharmexcil chief

Hyderabad: With the Indian pharma industry battling global headwinds, the sector needs to smarten up, especially when it comes to logistics — be it in ...
Read more: Pharma sector must cut logistics costs to stay in race: Pharmexcil chief

Pharma Reviews: Cipla to explore marketing tie-up with Novartis

Marketing arrangement and tie-ups between companies are common and ... Cipla, India's third largest drug maker, and Swiss giant Novartis are in ...
Read more: Cipla to explore marketing tie-up with Novartis

Pharma Reviews: GST to prolong pain for pharma sector finds HDFC securities

HDFC Securities' latest report on the outlook of the pharma industry paints a ... Granules India' revenue is expected to grow to a modest 5% YoY, with ...
Read more: GST to prolong pain for pharma sector finds HDFC securities

Pharma Reviews: Biopharma is Indian pharma's next frontier. It is also its Achilles' heel

When India's largest drugmaker chooses to go with a Korean contract manufacturer, it's a sign of changing times. Then, separately, comes the ...
Read more: Biopharma is Indian pharma's next frontier. It is also its Achilles' heel

Pharma Reviews: Indian Pharma market posts 7.5% growth in June 2017 at Rs.9463 cr

Indian Pharmaceutical market has registered satisfactory growth of 7.5 per cent during June 2017 to Rs.9,463 crore as major chronic therapy like ...
Read more: Indian Pharma market posts 7.5% growth in June 2017 at Rs.9463 cr

Pharma Reviews: Cipla, Novartis explore marketing tie-up

"Both the companies are in talks to co-market the anti-asthmatic drug Xolair in India," said a person with ... Cipla, one of the oldest domestic pharmaceutical companies, is strong in India's Rs 8,500 crore respiratory drug market, with a ...
Read more: Cipla, Novartis explore marketing tie-up

Pharma Reviews: Tide turns for pharma as US FDA concerns get addressed

In March, India's largest drug maker Sun Pharmaceutical informed about the FDA lifting ban on its Mohali plant, paving the way for resumption of ...
Read more: Tide turns for pharma as US FDA concerns get addressed

Pharma Reviews: We're seeing large huge investor interest worldwide in the India story: Abrar Mir

Singapore: Indian drug makers, whose business models have been under pressure as revenue from the US generic market grow at a slower pace, will ...
Read more: We're seeing large huge investor interest worldwide in the India story: Abrar Mir

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on National Academies of Sciences, Engineering, and Medicine report on pain management and prescription opioid abuse

In March 2016, the FDA asked the National Academies of Sciences, Engineering, and Medicine (NASEM) to outline the state of the science regarding prescription opioid abuse and misuse, as well as the evolving role that opioids play in pain management. We greatly appreciate all the work done by NASEM over the past year to produce the comprehensive report released today, which includes recommendations for the FDA and others on this important issue.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on National Academies of Sciences, Engineering, and Medicine report on pain management and prescription opioid abuse

Pharma Reviews: Q1 Earnings preview: Pharma to see muted growth due to pricing pressure in US, GST disruption ...

As Indian drug makers brace for the first quarter earnings in the days ahead, analysts are predicting the Q1 earnings to be muted with revenues ...
Read more: Q1 Earnings preview: Pharma to see muted growth due to pricing pressure in US, GST disruption ...

US FDA News: Statement from Alberto Gutierrez, Ph.D., Director, Office of In Vitro Diagnostics and Radiological Health, FDA’s Center for Devices and Radiological Health on the status of FDA’s investigation into inaccurate results from certain lead tests

On May 17, the U.S. Food and Drug Administration warned Americans that Magellan Diagnostics’ LeadCare test systems performed on blood drawn from the vein (venous) may provide inaccurate results.
Read more: Statement from Alberto Gutierrez, Ph.D., Director, Office of In Vitro Diagnostics and Radiological Health, FDA’s Center for Devices and Radiological Health on the status of FDA’s investigation into inaccurate results from certain lead tests

Pharma Reviews: Cadila's new MD Sharvil Patel says his vision is to build research-based pharma company

And that is what I want to see that world knows India as an innovative pharmaceutical company from India and also world knows that India can ...
Read more: Cadila's new MD Sharvil Patel says his vision is to build research-based pharma company

Pharma Reviews: Pharma is far from feeling healthy, GST adds to pain

While the former is preferred for its minimum exposure to the Indian market and GST rollout, absence of USFDA woes and attractive valuations, the ...
Read more: Pharma is far from feeling healthy, GST adds to pain

US FDA News: Sten Z and M1 Alpha Capsules by Andropharm: Recall - Contains Derivatives of Anabolic Steroids

Consumption of these products may cause elevated blood pressure, aggressive behavior, male infertility, or enlarged breasts and shrinkage of the testes in men.
Read more: Sten Z and M1 Alpha Capsules by Andropharm: Recall - Contains Derivatives of Anabolic Steroids

Pharma Reviews: Making prescription of generic drugs mandatory and associated issues

Questionable quality of generic drugs in India: According to the ... Over 90% of the Indian pharmaceutical industry is of branded generics and only ...
Read more: Making prescription of generic drugs mandatory and associated issues

Pharma Reviews: Indian pharma market grew at 7.5% in June amidst GST rollout concerns

The Indian pharmaceutical market grew 7.5 percent in June holding steady in the run-up to Goods and Service Tax (GST) rollout starting from July, ...
Read more: Indian pharma market grew at 7.5% in June amidst GST rollout concerns

Pharma Reviews: Nutrition and wellness – your companion for life

The Indian nutraceutical market is dominated by pharmaceuticals and fast-moving consumer goods (FMCG) giants. While dietary supplements such ...
Read more: Nutrition and wellness – your companion for life

Pharma Reviews: GST to have constructive effect on the Pharma and Healthcare sectors

India is a big hunting ground for the pharmaceutical sector; it is the largest ... The Indian Healthcare Industry is now among of the major sectors with ...
Read more: GST to have constructive effect on the Pharma and Healthcare sectors

Pharma Reviews: India to set up joint pharma venture in Russia, Pharmexcil seeks suggestions from industry

As India is planning to set up a joint pharmaceutical venture in Chelyainsk region of Russia, Union ministry of Commerce & Industry, has decided to ...
Read more: India to set up joint pharma venture in Russia, Pharmexcil seeks suggestions from industry

Pharma Reviews: Time To Reinvent

The question now is whether the industry can recover from this downturn ... The Indian Pharmaceutical Association (IPA) has finally found religion in ...
Read more: Time To Reinvent

Pharma Reviews: Boycott of Chinese goods: How it won't help India but can harm China

India's pharma sector has critical dependence on Chinese imports used in ... So even if Indians boycott all the goods imported form China, it will not ...
Read more: Boycott of Chinese goods: How it won't help India but can harm China

Pharma Reviews: Looking for a quick cure

This decade is looking very different for India's champion generic drug industry which went out and conquered the US and the rest of the world.
Read more: Looking for a quick cure

Pharma Reviews: Time To Reinvent

The industry is reeling from regulatory actions that enjoin it from exporting its product to its largest markets. The Indian Pharmaceutical Association ...
Read more: Time To Reinvent

Pharma Reviews: Going Beyond Generics

From being a net importer of pharmaceutical products in the '80s to the largest provider of generic drugs to global markets, the Indian pharma industry ...
Read more: Going Beyond Generics

Pharma Reviews: BSE Sensex mantra! Top factors which are pulling Indian markets higher: Adrian Mowat

The valuation of the Indian market is at the top band as there is a lot of .... So India's pharma companies having to deal with the firm rupee and a tough ...
Read more: BSE Sensex mantra! Top factors which are pulling Indian markets higher: Adrian Mowat

Pharma Reviews: On The Offensive

In our view, the future of Indian pharma is quite promising and not bleak, as is often portrayed these days. The Indian pharmaceutical companies that ...
Read more: On The Offensive

Pharma Reviews: 'We've To Be Ready For Scrutiny'

He inspects and regulates over 7,000 drug manufacturing companies in India. These companies are both domestic suppliers and exporters of bulk ...
Read more: 'We've To Be Ready For Scrutiny'

Pharma Reviews: Finding New Markets To Grow

Unfortunately for India, the existing market for copycat drugs — our forte — is drying up. To shore up its pharma exports, the government is ...
Read more: Finding New Markets To Grow

Pharma Reviews: Is It The End Of Pharma's Dream Run?

“We won't be able to get the desired subscription considering the dull health of the pharmaceutical industry in India,” R.C Juneja, CEO of Mankind ...
Read more: Is It The End Of Pharma's Dream Run?

Pharma Reviews: In The Spotlight For New Reasons

Several Indian drug companies and contract research organisations (CROs) faced serious charges of data manipulation, and were issued warning ...
Read more: In The Spotlight For New Reasons

Pharma Reviews: Indian big pharma R&D spend grows even as US growth slows

Indian pharma firms are gearing up to take on their global peers in terms of expenditure on research and development (R&D), which has shown a ...
Read more: Indian big pharma R&D spend grows even as US growth slows

Pharma Reviews: View: Today's pharma sector fits the bill for a contrarian bet

Of late, the Indian pharmaceutical space has been facing numerous headwinds in the form of US Food and Drug Administration (USFDA) con cerns ...
Read more: View: Today's pharma sector fits the bill for a contrarian bet

Pharma Reviews: need2know: 9 facts to know before starting your day on D-Street

Good news for Indian pharma companies which may see better performance in the stock market today. Indian pharmaceutical firm Lupin Ltd has ...
Read more: need2know: 9 facts to know before starting your day on D-Street

Pharma Reviews: Several new brands showcased in Pharmac South expo, 10% hike expected in business

The 3rd edition of the south Indian pharma industry's product profile expo, 'Pharmac South 2017', concluded on last Saturday, has served as an ideal ...
Read more: Several new brands showcased in Pharmac South expo, 10% hike expected in business

Pharma Reviews: Indian drug firms' R&D spending rises as growth slows in US, domestic mkts

Indian pharmaceutical companies are increasing expenditure on research and development (R&D) at a time when revenue growth from the domestic ...
Read more: Indian drug firms' R&D spending rises as growth slows in US, domestic mkts

Pharma Reviews: Dr Reddy's, Lupin, others mull expanding Africa operations

South Africa is the biggest market for Indian pharma companies and accounts for nearly a fifth of their exports to Africa. Cipla is the largest generic ...
Read more: Dr Reddy's, Lupin, others mull expanding Africa operations

Pharma Reviews: With Brexit we hope to see more companies from India set up a footprint in Ireland

During his visit to Bangalore, he spoke with BioSpectrum about the current status of pharma/ biotech industry in Ireland and role of Ireland after Brexit.
Read more: With Brexit we hope to see more companies from India set up a footprint in Ireland

Pharma Reviews: GNH India clears audit to trade orphan drugs

A global source for priority pharmaceuticals, GNH India is amongst the handful of Indian companies to clear an audit from one of the largest UK ...
Read more: GNH India clears audit to trade orphan drugs

Pharma Reviews: GNH India clears audit to trade orphan drugs with UK

GNH India, a global source for priority pharmaceuticals, is amongst the handful of Indian companies to clear an audit from one of the largest UK ...
Read more: GNH India clears audit to trade orphan drugs with UK

Pharma Reviews: Morning News Call - India, July 10

Lupin sets off down Indian pharma's long road to redemption In 28 years in India's pharmaceuticals sector, Rajiv Desai has never been busier. Most of ...
Read more: Morning News Call - India, July 10

Pharma Reviews: Drug serialisation: Packaging level terminology confusion is challenging for product exported from ...

India has put in place a system for serialisation and traceability to do its part in ensuring the security of the global pharmaceutical supply chain.
Read more: Drug serialisation: Packaging level terminology confusion is challenging for product exported from ...

Pharma Reviews: Indian pharma's long road to redemption

In 28 years in India's pharmaceuticals sector, Rajiv Desai has never been busier. Most of the last six months on his calendar is marked green, ...
Read more: Indian pharma's long road to redemption

Pharma Reviews: Lupin sets off down Indian pharma industry's long road to redemption

Drug firms have spent millions of dollars on training, new equipment and foreign consultants. Yet the Indian Pharmaceutical Alliance of the top 20 firms ...
Read more: Lupin sets off down Indian pharma industry's long road to redemption

Pharma Reviews: Pharma funds miss the party

An important reason for this is growth concerns in the key market, the US, on two counts. One, supply disruptions to the US by select Indian pharma ...
Read more: Pharma funds miss the party

Pharma Reviews: GlaxoSmithKline Pharma to invest Rs 1000 crore in Karnataka plant

GlaxoSmithKline Pharma to invest Rs 1,000 crore in Karnataka plant ... at enhancing its global pipeline in areas like respiratory drugs and vaccines in India. "We are investing Rs 1,000 crore in a new state-of-the- art pharmaceutical ...
Read more: GlaxoSmithKline Pharma to invest Rs 1000 crore in Karnataka plant

Pharma Reviews: Lupin sets off down Indian pharma's long road to redemption

Employees inspect tablets as they move along the production line at a pharmaceutical plant of Lupin, India's No. 2 drugmaker, in Verna, Goa, June 9, ...
Read more: Lupin sets off down Indian pharma's long road to redemption

Pharma Reviews: Lupin sets off down Indian pharma's long road to redemption

Drug companies have spent millions of dollars on training, new equipment and foreign consultants. Yet the Indian Pharmaceutical Alliance of the top ...
Read more: Lupin sets off down Indian pharma's long road to redemption

Pharma Reviews: GST opens up big opportunities for Pharma SMEs: Ex Prez IDMA

GST opens up big opportunities for Pharma SMEs: Ex Prez IDMA ... Past President of the Indian Drug Manufacturers Association (IDMA) said recently.
Read more: GST opens up big opportunities for Pharma SMEs: Ex Prez IDMA

Pharma Reviews: Pharmac South-2017' opens in Chennai with call to augment export contribution from South India

Dr. J. Radhakrishnan, principal secretary to health, government of Tamil Nadu has inaugurated this year's south Indian pharmaceutical and ...
Read more: Pharmac South-2017' opens in Chennai with call to augment export contribution from South India

Pharma Reviews: NIPER Ahmedabad seeks sponsorship from medical device industry for PhD programmes to boost ...

NIPER Ahmedabad seeks sponsorship from medical device industry for ... for indigenous manufacturing, National Institute of Pharmaceutical Education ... Ahmedabad is also planning to collaborate with leading Indian companies for ...
Read more: NIPER Ahmedabad seeks sponsorship from medical device industry for PhD programmes to boost ...

Pharma Reviews: Price of life-saving drugs set to increase

CHENNAI: The prices of essential medicines are likely to rise marginally, as the National Pharmaceutical Pricing Authority (NPPA) has allowed Indian ...
Read more: Price of life-saving drugs set to increase

Pharma Reviews: Sun Pharma enters settlement in antitrust litigation in US

NEW DELHI: Indian pharmaceutical giant Sun Pharmaceutical Industries Ltd and one of its wholly-owned subsidiaries have entered into settlements ...
Read more: Sun Pharma enters settlement in antitrust litigation in US

Pharma Reviews: Pharmac South 2017 meet in Chennai

Small and medium scale pharmaceutical enterprises should invest in newer ... SV Veeramani, past president, Indian Drug Manufacturers Association, said there ... Earlier, many companies preferred the firms in excise-free zones for ...
Read more: Pharmac South 2017 meet in Chennai

Pharma Reviews: FIPB abolition is regressive

Transnational pharmaceutical majors used the policy's failure to distinguish between brownfield and greenfield investments to buy out major Indian companies. The case of Ranbaxy and Nicholas Piramal's domestic formulations ...
Read more: FIPB abolition is regressive

Pharma Reviews: The old order changeth in Indian pharma landscape

It's the elephant in the room, says pharma industry veteran Ranjit Shahani, on the challenge of handing over the reins of a company to the next ...
Read more: The old order changeth in Indian pharma landscape

Pharma Reviews: GST rollout to hit earnings of pharma cos' domestic formulation biz in first half of FY18

Indian drug makers' domestic formulation businesses could be under strain, impacting their overall profits in the first half of this financial year, owing to ...
Read more: GST rollout to hit earnings of pharma cos' domestic formulation biz in first half of FY18

Pharma Reviews: Ajanta Pharma focuses on US; plans to file 15 ANDAs in FY18

... a dozen ANDAs with the regulator in the world's largest pharma market. The Indian drugmaker said it plans to file 12-15 ANDAs (abbreviated new ...
Read more: Ajanta Pharma focuses on US; plans to file 15 ANDAs in FY18

US FDA News: FDA approves new treatment for sickle cell disease

The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder.
Read more: FDA approves new treatment for sickle cell disease

Pharma Reviews: Drug generic name prescription may hit companies' profit: ICRA

Mumbai: The recent move by the government to ask doctors to prescribe drug generic name may lead to 5-10 per cent drop in value of the Indian ...
Read more: Drug generic name prescription may hit companies' profit: ICRA

Pharma Reviews: Two-day Pharmac South, organised by IDMA, launched

The third Edition of Pharmac South organised by Indian Drug Manufacturers' Association (IDMA) was today inaugurated by Tamil Nadu Health ...
Read more: Two-day Pharmac South, organised by IDMA, launched

Pharma Reviews: Modi addresses first India-Israel CEOs meet

"New chapter has been opened in India-Israel relations. ... Among Israeli companies present at the meeting were Teva Pharmaceutical Industries, ...
Read more: Modi addresses first India-Israel CEOs meet

Pharma Reviews: Government Tells Exporters To Hunt For New Pharma Export Destinations

Pharmaceutical exports, otherwise, were tagged as the next big thing for India post the successful stint of country's IT industry. In the last financial year, ...
Read more: Government Tells Exporters To Hunt For New Pharma Export Destinations

Pharma Reviews: Markets Live: Sensex, Nifty consolidate, pharma, realty stocks rise

But broader losses in India were capped as some drug makers such as Lupin Ltd recovered from recent ... 9.40am: Pharma companies trading higher.
Read more: Markets Live: Sensex, Nifty consolidate, pharma, realty stocks rise

Pharma Reviews: Govt flouts Delhi HC order to ban 5 FDCs, affected cos seek stay

The FDCs ban does not augur well for Indian pharma industry which is one of the rapidly growing industry in the world. It reflects uncertainty over ...
Read more: Govt flouts Delhi HC order to ban 5 FDCs, affected cos seek stay

US FDA News: Atar Extension Cables by Oscor: Recall - Cable Separating from Connector

For pacing dependent patients, an interruption of pacing system could result in serious injury or death if not detected. Posted 07/06/2017
Read more: Atar Extension Cables by Oscor: Recall - Cable Separating from Connector

Pharma Reviews: African countries invite investment from India Inc

"As much as 30% of our pharmaceutical import is from India. At the same time, the most preferred destination of treatment is India. So investment in ...
Read more: African countries invite investment from India Inc

US FDA News: Novopen Echo Insulin Delivery Device by Novo Nordisk: Recall - May Crack or Break If Exposed To Certain Chemicals

Using a device with a cracked/broken cartridge holder may result in the device delivering a reduced dose of insulin which could potentially lead to high blood sugar.
Read more: Novopen Echo Insulin Delivery Device by Novo Nordisk: Recall - May Crack or Break If Exposed To Certain Chemicals

Pharma Reviews: African delegations interacts with Coimbatore businessmen

"As much as 30% of our pharmaceutical import is from India. At the same time, the most preferred destination of treatment by Ugandans is India.
Read more: African delegations interacts with Coimbatore businessmen

US FDA News: Vascu-Guard Peripheral Vascular Patch by Baxter International: Letter to Health Care Providers - Potential Risk of Severe Bleeding and Hematomas

UPDATED 07/06/2017. Voluntary recall closed on June 23, 2017. FDA continues to recommend that health care providers discuss with their patients all available treatment options for CEA surgery.
Read more: Vascu-Guard Peripheral Vascular Patch by Baxter International: Letter to Health Care Providers - Potential Risk of Severe Bleeding and Hematomas

US FDA News: Ultra-Sten and D-Zine Capsules by Hardcore Formulations: Recall - Contains Anabolic Steroids

Consumption of products containing derivatives of anabolic steroids may cause serious liver injury and other adverse health consequences, including kidney injury, increased risk of heart attack and stroke.
Read more: Ultra-Sten and D-Zine Capsules by Hardcore Formulations: Recall - Contains Anabolic Steroids

Pharma Reviews: Govt's push for generic drugs may lead to 5-10% fall in pharmaceutical market value: ICRA

New Delhi: The government's push for generic medicines may lead to an estimated 5-10% reduction in value of Indian Pharmaceutical Market (IPM) if ...
Read more: Govt's push for generic drugs may lead to 5-10% fall in pharmaceutical market value: ICRA

Pharma Reviews: Modi addresses first India-Israel CEOs meet, $5 bn worth MoUs inked

Modi addresses first India-Israel CEOs meet, $5 bn worth MoUs inked ... Among Israeli companies present at the meeting were Teva Pharmaceutical ...
Read more: Modi addresses first India-Israel CEOs meet, $5 bn worth MoUs inked

Pharma Reviews: Stronger rupee damps pharma firms' profit

The latter development means Indian companies earn less in rupee terms for ... Lupin and Sun Pharma posted strong revenue growth since they had ...
Read more: Stronger rupee damps pharma firms' profit

Pharma Reviews: Modi addresses first India-Israel CEOs meet, $5 bn worth MoUs inked

Among Israeli companies present at the meeting were Teva Pharmaceutical Industries, Mekorot Water Company, Check Point Software, Israel Electric ...
Read more: Modi addresses first India-Israel CEOs meet, $5 bn worth MoUs inked

Pharma Reviews: Generics only prescription if implemented will shave-off significant value of Indian pharmaceutical ...

Generics only prescription if implemented by the government could potentially shave-off between 5-10 percent value of the Rs 1.15 trillion Indian ...
Read more: Generics only prescription if implemented will shave-off significant value of Indian pharmaceutical ...

Pharma Reviews: Drug generic name prescription may hit companies profit: ICRA

Drug generic name prescription may hit companies profit: ICRA ... drop in value of the Indian pharma market (IPM) and dent profitability of companies, ...
Read more: Drug generic name prescription may hit companies profit: ICRA

US FDA News: Federal judge enters consent decree against Alabama compounder Medistat

U.S. District Judge William H. Steele entered a consent decree of permanent injunction yesterday between the United States and Medistat RX LLC of Foley, Alabama, the company’s co-owners, Mark D. Acker and Timothy L. Fickling, and quality manager and pharmacist-in-charge V. Elaine Waller.
Read more: Federal judge enters consent decree against Alabama compounder Medistat

Pharma Reviews: USFDA commissioner's comments raise new hopes for Indian pharma

The past few days have been a mixed bag for the Indian pharma industry. There have been fresh concerns related to the transition to a Goods and ...
Read more: USFDA commissioner's comments raise new hopes for Indian pharma

Pharma Reviews: US FDA defers implementation of 2nd phase of Drug Supply Chain Security Act by a year

This came as a major relief for a majority of Indian pharmaceutical companies which were under pressure to lose their US market share due to their ...
Read more: US FDA defers implementation of 2nd phase of Drug Supply Chain Security Act by a year

Pharma Reviews: Dr J Radhakrishnan to inaugurate Pharmac South 2017 in Chennai on July 7.

M Rajaratinam, chairman of Pharmac South, said the Pharmac South 2017 is aimed to showcase south Indian pharmaceutical industry's capabilities ...
Read more: Dr J Radhakrishnan to inaugurate Pharmac South 2017 in Chennai on July 7.

Pharma Reviews: Beijing debt alarm puts spotlight on Fosun, Wanda deals in India

Last year, Fosun Pharmaceutical (Group) Co. Ltd, the Hong Kong-listed firm controlled by Fosun International, acquired India's Gland Pharma Ltd for ...
Read more: Beijing debt alarm puts spotlight on Fosun, Wanda deals in India

Pharma Reviews: Pharma Industry Makes It Reservation About 'Vegetarian' Pills Clear: Report

A New Indian Express report quoted M Rajarathinam, former president of the Indian Drug Manufacturers Association, Tamil Nadu as saying, "On one ...
Read more: Pharma Industry Makes It Reservation About 'Vegetarian' Pills Clear: Report

Pharma Reviews: Pharma stocks edge higher

Shares of psu coal mining major Coal India gained 0.06%. ... Sun Pharmaceutical Industries (up 0.22%), Aurobindo Pharma (up 0.2%), Cipla (up ...
Read more: Pharma stocks edge higher

Pharma Reviews: GST ON PHARMA SECTOR

The national president of Indian Drug Manufacturers Association had made it clear last week that some sections of the pharma trade are not yet ...
Read more: GST ON PHARMA SECTOR

Pharma Reviews: Desi pharma companies need not fear Amazon in US

MUMBAI: Indian generic companies that retail in the US can breathe easy . Amazon's reported entry in the US pharmacy business does not pose a ...
Read more: Desi pharma companies need not fear Amazon in US

Pharma Reviews: Indian pharma cos secure 138 ANDA approvals from US FDA during first half ended June 2017

Indian pharmaceutical companies have successfully gained higher approval for ANDAs from US FDA during last couple of years. For the first half ...
Read more: Indian pharma cos secure 138 ANDA approvals from US FDA during first half ended June 2017

Pharma Reviews: Desi pharma cos need not fear Amazon in US

Mumbai: Indian generic companies that retail in the US can breathe easy. Amazon's reported entry in the US pharmacy business does not pose a ...
Read more: Desi pharma cos need not fear Amazon in US

Pharma Reviews: Indian firms' drug approvals by US rise 50% in 2017

At a time when the US business for the Indian pharmaceutical industry is in slow lane, drug approvals by the US Food and Drug Administration (FDA) ...
Read more: Indian firms' drug approvals by US rise 50% in 2017

Pharma Reviews: Drug exporters under pressure

The India pharma companies, which are already under pressure due to some quality related issues raise by US FDA, are facing uncertainties over ...
Read more: Drug exporters under pressure

Pharma Reviews: BSE Healthcare index remained under pressure in first half of 2017

The poor financial performances by the pharma majors, warning letters. from ... Further, out of 85 tentative approvals, Indian companies grabbed 32 ...
Read more: BSE Healthcare index remained under pressure in first half of 2017

Pharma Reviews: Aggregate Indian pharma segment growth expected to come down to single digit: ICRA

The growth trajectory for Indian pharmaceutical industry is likely to be moderate on back of slowing growth from US given the relatively moderate ...
Read more: Aggregate Indian pharma segment growth expected to come down to single digit: ICRA

Pharma Reviews: Samsung Biologics to manufacture Sun Pharma's new psoriasis drug

Sun Pharma, India's largest drug maker, had acquired rights for ... the Indian company's new drug for treatment of moderate-to-severe plaque psoriasis ...
Read more: Samsung Biologics to manufacture Sun Pharma's new psoriasis drug

Pharma Reviews: Icra sees pharma industry growth tapering to 7-10% over FY18-FY20

Mumbai: The Indian pharmaceutical industry is likely to witness a slowdown in growth over the next three years because of pricing pressure and ...
Read more: Icra sees pharma industry growth tapering to 7-10% over FY18-FY20

Pharma Reviews: All you wanted to know about...US FDA FORM 483

The Indian pharmaceutical industry has been through a tough time. One major pain point is regulatory clampdown, especially from the US FDA (Food ...
Read more: All you wanted to know about...US FDA FORM 483

US FDA News: FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy

Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in cancer patients with solid tumors.
Read more: FDA clears expanded use of cooling cap to reduce hair loss during chemotherapy

Pharma Reviews: Indian pharma revenue growth to cool off in next 3 years: ICRA

In spite of these ongoing challenges, the ICRA report says several Indian pharma companies have ramped up their R&D spend, targeting pipeline of ...
Read more: Indian pharma revenue growth to cool off in next 3 years: ICRA

Pharma Reviews: Indian pharma sector growth to moderate in next 3 years: ICRA

According to ICRA, the Indian pharmaceutical industry is likely to show moderate growth in the next three years mainly due to decline in revenues from ...
Read more: Indian pharma sector growth to moderate in next 3 years: ICRA

Pharma Reviews: Indian pharma sector growth to moderate in next 3 years: ICRA

NEW DELHI: Indian pharmaceutical industry is likely to witness moderation in growth in the next three years mainly due to decline in revenues from ...
Read more: Indian pharma sector growth to moderate in next 3 years: ICRA

Pharma Reviews: Indian pharma sector growth to moderate in next 3 yrs: ICRA

New Delhi, Jul 3 Indian pharmaceutical industry is likely to witness moderation in growth in the next three years mainly due to decline in revenues from ...
Read more: Indian pharma sector growth to moderate in next 3 yrs: ICRA

Pharma Reviews: Strides Shasun receives USFDA nod to market nausea drug in US

Bengaluru-based Indian pharmaceutical major Strides Shasun has announced that the company has received approval from US Food and Drug ...
Read more: Strides Shasun receives USFDA nod to market nausea drug in US

Pharma Reviews: Innovate in India (i3) programme launched by the Government

Dr Harsh Vardhan stated “This Mission is anticipated to be a game changer for the Indian Bio-pharmaceutical industry. It aspires to create an enabling ...
Read more: Innovate in India (i3) programme launched by the Government

Pharma Reviews: 'Indian Pharma Sector Growth Likely To Come Down To Single Digit'

In ICRA's view, continued regulatory interventions in domestic market will put some pressure in near term though long term growth prospects remain ...
Read more: 'Indian Pharma Sector Growth Likely To Come Down To Single Digit'

Pharma Reviews: GST set to transform face of Indian logistics industry

“Manufacturing, modern retail and the pharma sector were already driving change in Indian warehousing. GST has just fast-tracked the growth rate in ...
Read more: GST set to transform face of Indian logistics industry